ArticleFrontiers in public health2026
Strengthening public understanding and prevention of dengue in Malaysia: insights and recommendations based on knowledge, attitudes, and practices toward vector control and vaccination.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Malaysia continues to experience a high dengue burden, despite long-standing national education and control efforts. This study aimed to examine public Knowledge, Attitudes, and Practices related to dengue prevention, with a focus on informing more targeted education, vector control, and vaccination strategies. Methods: This study analysed Malaysia-specific data from the publication Knowledge, Attitudes and Practices toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in Countries from Latin America and Asia-Pacific: A Cross-Sectional Study (Growth and Emerging Markets Knowledge, Attitude and Practice [GEMKAP]) conducted between September and October 2022. A total of 400 adults aged 18-60 from Malaysia completed the online questionnaire, which assessed dengue-related knowledge, attitudes, practices, and vaccine willingness. Results: Awareness of dengue transmission was high, however, misconceptions about reinfection risks, availability of a cure, and vaccine safety remain. Knowledge score (46%) aligned with global and Asia-Pacific averages, while Attitude (61%) and Practice (46%) scores were slightly lower than global benchmarks (66 and 48%, respectively). Although most respondents perceived dengue as a serious threat and reported removing stagnant water as a preventive measure, more intensive actions were less commonly practised. A total of 41% expressed high willingness to receive a dengue vaccine, as measured before a dengue vaccine TAK-003 (Qdenga) became available in Malaysia. Key barriers included concerns about side effects and insufficient information. Subgroup analysis showed higher willingness to vaccinate among respondents with prior dengue exposure, strong perceptions of disease severity, a generally pro-vaccine stance, and prior COVID-19 vaccination. While healthcare professionals were widely trusted sources of dengue information, this did not translate into higher vaccine acceptance. In addition, 40% of Malaysian respondents supported a multi-pronged dengue prevention strategy incorporating vaccination, education, and vector control. Conclusion: Future prevention efforts should prioritise coordinated messaging led by the Ministry of Health, through a multi-stakeholder task force involving healthcare professionals and community leaders. Efforts should focus on addressing misconceptions on dengue and vaccination, strengthening communication through trusted channels, and promoting more consistent adoption of vector control practices. Improving access to clear and reliable information on dengue vaccines will be critical to reducing hesitancy and supporting uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.